Received May 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 947985 | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | TL74Y | IM / LA |
Patient came in for 2nd dose of both Shingrix and Heplisav-b. Chief complaints are this injection feels much worse than previous with notably more soreness at the injection site and feeling very sick including symptoms of nausea, "shakes", and a fever of 101 F. Patient had Zofran on hand to mitigate the nausea was advised to take an antipyretic for the fever and to call if symptoms persist.
no reported illnesses
no known health conditions
not known
nkda
none